Companies

InnoCare Pharma

Mentioned in 1 analyzed podcast episode across 1 show

Episode Mentions

Pharma and BioTech Daily

Pharma and BioTech Daily · Jul 28, 2026

AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily

Announced successful phase 3 results for oral TYK2 inhibitor faducravacitinib in moderate to severe plaque psoriasis

Antibody-Drug Conjugates (ADCs) in OncologyNon-Stimulant ADHD TherapeuticsDuchenne Muscular Dystrophy (DMD) Treatments
View Analysis